Prognostic factors related with survival in patients with pancreatic adenocarcinoma
MetadataShow full item record
CitationBilici, A. (2014). Prognostic factors related with survival in patients with pancreatic adenocarcinoma. World Journal of Gastroenterology, 20(31), 10802-10812. https://dx.doi.org/10.3748/wjg.v20.i31.10802
The prognosis in patients with pancreatic cancer is poor and this cancer is the fourth leading cause of cancer-related death worldwide. Although surgical resection is the only curative treatment of choice for pancreatic cancer, the majority of patients are diagnosed at an advanced stage, thus only 10%-15% of them are suitable for curative resection and the overall survival is less than 5%. Chemotherapy for metastatic disease is to palliate symptoms of patients and to improve survival. Therefore, prognostic factors are important and a correct definition of poor prognostic factors may help to guide more aggressive adjuvant or aggressive treatment protocols in patients with pancreatic cancer. This article reviews the prognostic factors affecting survival of patients with pancreatic cancer in the light of recent advances in the literature.